Chapter 6: Concepts of Genetics and Genomics
Loading audio…
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
The distinction between genetics, which focuses on inheritance of single traits, and genomics, which examines the entire genome's contribution to health outcomes, establishes the framework for understanding disease susceptibility and personalized medicine. Students learn DNA structure, gene function, alleles, and protein synthesis mechanisms that underlie cellular regulation and phenotypic expression. The chapter systematically presents inheritance patterns including autosomal dominant traits exemplified by Huntington disease, autosomal recessive conditions such as cystic fibrosis and sickle cell disease, and sex-linked recessive disorders like hemophilia, while introducing concepts of penetrance and expressivity to explain variable clinical manifestations among individuals with identical genetic mutations. Epigenetic mechanisms including DNA methylation, histone modification, and microRNA regulation are explored as processes that alter gene expression without changing DNA sequences, alongside the emerging understanding of how the human microbiome influences genetic function. The chapter addresses diagnostic, presymptomatic, predisposition, and carrier testing approaches with attention to both clinical benefits and potential psychosocial consequences including genetic discrimination and psychological burden. Direct-to-consumer genetic testing receives critical examination regarding limitations in clinical validity and interpretation. Ethical practice standards including informed consent, nondirective counseling, confidentiality protection, and patient advocacy are presented as fundamental nursing responsibilities. Nurses are positioned as members of interprofessional teams providing education, support, and counseling as patients navigate genetic risk assessment and decision-making. The chapter concludes with emerging gene therapy applications including CRISPR-Cas9 technology, stem cell interventions, and FDA-approved approaches to correcting inherited mutations, representing the trajectory of precision health in clinical practice.